Norethindrone Acetate And Ethinyl Estradiol
Product Images NDC 0378-7283

8 FDA label images from Mylan Pharmaceuticals Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Norethindrone Acetate And Ethinyl Estradiol (NDC 0378-7283). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Graph (6ba530ce 2499 4963 850e 620b8956af7b 02)

Graph (6ba530ce 2499 4963 850e 620b8956af7b 02)
A bar graph depicting mortality rates (number of deaths per 100,000 woman users) by age group among ever-users and controls, separated into smokers and non-smokers. The age groups include 15-24, 25-34, 35-44, and 45+. The graph shows mortality rates for four categories: ever-users (non-smokers), controls (non-smokers), ever-users (smokers), and controls (smokers), with mortality increasing notably in the 45+ age group especially for ever-users who smoke.*
FDA Label Image

Blister Image With Instructions (6ba530ce 2499 4963 850e 620b8956af7b 03)

Blister Image With Instructions (6ba530ce 2499 4963 850e 620b8956af7b 03)
This image shows a medication dose calendar for NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL tablets. It includes a weekly pill organizer with circles for days Sunday through Saturday arranged in four weekly rows, and instructions to start based on period timing. Dosage instructions indicate taking pills left to right each week. The label notes the active ingredients and storage conditions.*
FDA Label Image

Day Label Sticker (6ba530ce 2499 4963 850e 620b8956af7b 04)

Day Label Sticker (6ba530ce 2499 4963 850e 620b8956af7b 04)
An instructional diagram showing the placement of a day label strip on a blister pack for NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL. It displays day labels arranged in rows and provides directions to align the starting day of the period with the days of the week on the blister pack, beginning with Sunday.*
FDA Label Image

Blister Image With Instructions (6ba530ce 2499 4963 850e 620b8956af7b 05)

Blister Image With Instructions (6ba530ce 2499 4963 850e 620b8956af7b 05)
Medication guide panel for NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL tablets, showing a weekly pill schedule for 28 tablets. Instructions specify how to start taking the medication on Sunday or day 1 of the period, with arrows indicating progression from left to right across four weeks. Storage temperature guidance and tablet composition are noted at the bottom.*
FDA Label Image

Day Sticker Label (6ba530ce 2499 4963 850e 620b8956af7b 06)

Day Sticker Label (6ba530ce 2499 4963 850e 620b8956af7b 06)
An instructional calendar strip showing days of the week arranged in rows, designed to align with a medication blister pack for tracking daily doses starting from the first day of a menstrual period. The step includes placing the strip so Sunday is preprinted on the blister, with a note explaining to skip if the period starts on Sunday.*
FDA Label Image

Image 01

Image 01
Carton label for Norethindrone Acetate and Ethinyl Estradiol and Ferrous Fumarate Tablets USP, 1 mg/0.02 mg, by Mylan Pharmaceuticals Inc. The label indicates each blister pack contains 28 tablets including 21 white to off-white tablets and 7 brown tablets, packaged in 3 pouches. The label highlights dosage strengths and includes manufacturer information and storage instructions.*
FDA Label Image

Image 02

Image 02
Chemical structures of the active ingredients Ethinyl Estradiol and Norethindrone Acetate. The diagram shows the molecular formulas with labels for each compound: Ethinyl Estradiol at the top and Norethindrone Acetate below it.*
FDA Label Image

Image 03

Image 03
A forest plot chart illustrating effect estimates from various studies comparing risk or odds ratios for Ever COC use versus Never COC use and Current COC use versus Never-Use. The chart lists study names and years on the left, with points and confidence intervals graphically displayed on a horizontal effect estimate axis, ranging approximately from -1.5 to 2.0, with numerical results shown on the right side for each study.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.